Current Therapeutic Research Publication

Current Therapeutic Research Publication
Copy URL
Salt Lake City, UT (October 26, 2023) 4Life Research and Development scientists published their findings in a peer-reviewed scientific journal: Current Therapeutic Research. The studies measured the immunomodulatory effects of 4Life Transfer Factor® and 4Life Transfer Factor products.

Vice President of Product Development Lawry Han, PhD, FACN; Chief Scientific Officer David Vollmer, PhD; and Health Sciences Advisory Board member Elena Y. Enioutina, MD, PhD coauthored the newly published research article: “Immunomodulatory Effects of Modified Bovine Colostrum, Whey, and Their Combination with Other Natural Products: Effects on Human Peripheral Blood Mononuclear Cells.”

Vollmer: “That’s a really long title for findings that are simple, yet important: 4Life Transfer Factor can do more than just boost immune function. While we’ve demonstrated 4Life Transfer Factor’s immune-activating benefits across many different studies, our latest data reveals that 4Life Transfer Factor can also calm overactive immune function’s. This new, independent research has wide-ranging applications across many aspects of wellness, particularly for those who can benefit from balancing immune health.”

The researchers studied a variety of 4Life proprietary products and formulas: 4Life® Transfer Factor Plus® Tri-Factor® Formula, UltraFactor® in 4Life Transfer Factor® Classic, NanoFactor®, OvoFactor®, Tri-Factor® Formula in 4Life Transfer Factor Plus Tri-Factor Formula, the supermushroom blend in the botanical blend of 4Life Transfer Factor Plus Tri-Factor Formula, and the whey protein concentrate in NutraStart® Blue Vanilla.

All ingredients studied showed positive effects in modulating innate and adaptive immune function activity.

4Life, Do Life Differently®, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.

For more information:
Calvin Jolley
Vice President Corporate Communications
4Life Research
[email protected]